Andrew Murphy - Dec 16, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research
Signature
/s/**Andrew Murphy
Stock symbol
REGN
Transactions as of
Dec 16, 2022
Transactions value $
$0
Form type
4
Date filed
12/20/2022, 03:08 PM
Previous filing
Dec 13, 2022
Next filing
May 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Award $0 +4.13K +7.29% $0.00 60.7K Dec 16, 2022 Direct F1
holding REGN Common Stock 4.29K Dec 16, 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +15.2K $0.00 15.2K Dec 16, 2022 Common Stock 15.2K $726.53 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.